En esta página
01VOR precio
02Instantánea
03Gráfico
04Divisiones de acciones
06Rendimiento
07Valoración y ratios
13Dividendos
14Ganancias
15Fundamentales Completos
16Estados Financieros
17Propietarios institucionales (13F)
18Activistas y propietarios del %+ 5
19Informantes de la empresa
20Propiedad de ETFs
21Consenso
22Pares
26Mis Métricas
VOR Vor Biopharma Inc. - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ 10-K/10-Q Ago 11, 2026
$18,26
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$6,50mínimo 52 semanas
$28,66máximo 52 semanas
Capitalización Bursátil (MRQ)
$994M
P/E
-0.4
BPA
$-70.50
tus insignias
Rango 52S
$6–$29
Calificación del Analista
BUY
Precio Objetivo
$39
P/E
-0.4
ROE
83.4%
Margen de Beneficio Neto
·
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
VOR Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$18.26
Capitalización Bursátil (MRQ)
$994M
P/E
-0.4
BPA
$-70.50
Rendimiento div.
0.00%
ROE
83.4%
Rango 52S
$7–$29
VOR Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Divisiones de acciones
| Fecha ex-dividendo | División | Tipo |
|---|---|---|
| 19 de septiembre de 2025 | 1-for-20 | Inversa |
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
BPA$-70.502021-12-31 → 2025-12-31
Flujo de caja libre$-144M2021-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | VOR | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E | -0.4promedio 5A ≈-38.9 | ≈-38.9 | · | · | |
| P/C (MRQ) | -5.0promedio 5A ≈24.2 | ≈24.2 | · | · | |
| Precio / FCF (TTM) | -7.1promedio 5A ≈-54.7 | ≈-54.7 | · | · | |
| Precio / Flujo de Caja (TTM) | -7.1promedio 5A ≈-58.0 | ≈-58.0 | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 56.0promedio 5A ≈31.0 | ≈31.0 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | VOR | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| ROA | -229.3%promedio 5A ≈-84.5% | ≈-84.5% | -48.2% | Débil | |
| ROE | 83.4%promedio 5A ≈-40.5% | ≈-40.5% | -53.2% | De primer nivel |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | VOR | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 19.1promedio 5A ≈14.3 | ≈14.3 | 10.9 | Liquidez sólida | |
| Quick Ratio (Ratio Rápido) | 18.1promedio 5A ≈14.0 | ≈14.0 | 10.6 | Liquidez sólida |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Dividendos Rendimiento, ratio de pago, historial de dividendos, CAGR a 5 años
Rendimiento por Dividendo0.00%
Ratio de Pago0.00%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
79.0%
Próximo informe
Nov 11, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 10, 2026 | $-1.16 | $-0.71 | -63.1% |
| 31 de marzo de 2026 | May 13, 2026 | $-5.11 | $-0.79 | -548.3% |
| 31 de diciembre de 2025 | $25.84 | $-1.69 | 1625.3% | |
| 30 de septiembre de 2025 | $-3.33 | $-3.28 | -1.4% | |
| 30 de junio de 2025 | $-43.80 | $-8.86 | -394.6% | |
| 31 de marzo de 2025 | $-5.20 | $-4.62 | -12.6% | |
| 31 de diciembre de 2024 | $-8.80 | $-5.77 | -52.5% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $322M | $93M | $94M | $65M | $48M | $32M | |
| SG&A Expense | $50M | $28M | $32M | $29M | $21M | $12M | |
| Operating Expenses | $372M | $121M | $126M | $93M | $69M | $43M | |
| Operating Income | $-372M | $-121M | $-126M | $-93M | $-69M | $-43M | |
| Interest Income | $6M | $4M | $8M | $1M | $119.0K | $29.0K | |
| Other Non-op | $-324M | $4M | $8M | $1M | $119.0K | $29.0K | |
| Net Income | $-696M | $-117M | $-118M | $-92M | $-69M | $-43M | |
| EPS (Basic) | $-70.50 | $-34.03 | $-1.75 | $-2.33 | $-2.10 | · | |
| EPS (Diluted) | $-70.50 | $-34.03 | $-1.75 | $-2.33 | $-2.10 | · | |
| Shares (Basic) | 9,871,866 | 3,435,533 | 67,191,973 | 39,551,420 | 33,433,214 | · | |
| Shares (Diluted) | 9,871,866 | 3,435,533 | 67,191,973 | 39,551,420 | 33,433,214 | · | |
| EBITDA | $-372M | $-121M | $-126M | $-93M | $-69M | · |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $396M | $82M | $31M | $58M | $120M | $49M | |
| Short-term Investments | $59M | $10M | $106M | $173M | $88M | $0 | |
| Prepaid Expense | $1M | $4M | $3M | $4M | $5M | $467.0K | |
| Other Current Assets | $2M | $380.0K | $475.0K | $2M | $2M | $100.0K | |
| Current Assets | $458M | $97M | $141M | $237M | $214M | $49M | |
| PP&E (Net) | $533.0K | $7M | $10M | $13M | $7M | $5M | |
| PP&E (Gross) | $558.0K | $18M | $18M | $17M | $9M | $5M | |
| Accum. Depreciation | $25.0K | $11M | $8M | $5M | $2M | $726.0K | |
| Other Non-current Assets | $2M | $2M | $5M | $3M | $3M | $3M | |
| Total Assets | $464M | $143M | $198M | $299M | $243M | $76M | |
| Accounts Payable | $5M | $2M | $815.0K | $2M | $2M | $2M | |
| Accrued Liabilities | $20M | $13M | $11M | $8M | $6M | $6M | |
| Current Liabilities | $25M | $19M | $16M | $13M | $10M | $10M | |
| Capital Leases | $3M | $28M | $32M | $36M | $16M | $17M | |
| Total Liabilities | $628M | $46M | $47M | $49M | $26M | $28M | |
| Common Stock | $18.0K | $13.0K | $7.0K | $7.0K | $4.0K | $1.0K | |
| Retained Earnings | $-1.15B | $-457M | $-340M | $-222M | $-130M | $-61M | |
| AOCI | $41.0K | $22.0K | $-77.0K | $-770.0K | · | · | |
| Stockholders' Equity | $-164M | $97M | $151M | $251M | $216M | $-59M | |
| Liabilities + Equity | $464M | $143M | $198M | $299M | $243M | $76M | |
| Shares Outstanding | 38,720,196 | 6,238,799 | 3,395,072 | 65,996,138 | 37,174,741 | 505,074 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $19M | $10M | $13M | $11M | $4M | $1M | |
| Restructuring | $30M | · | · | · | · | · | |
| Operating Cash Flow | $-143M | $-100M | $-100M | $-85M | $-69M | $-36M | |
| CapEx | $941.0K | $229.0K | $1M | $8M | $4M | $4M | |
| Investing Cash Flow | $-49M | $97M | $71M | $-94M | $-92M | $-4M | |
| Stock Issued | $70M | $275.0K | $5M | $4M | · | · | |
| Net Stock Activity | $70M | $275.0K | $5M | $4M | · | · | |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | |
| Financing Cash Flow | $504M | $53M | $3M | $117M | $233M | $83M | |
| Net Change in Cash | $312M | $51M | $-26M | $-62M | $72M | $42M | |
| Free Cash Flow | $-144M | $-100M | $-101M | $-94M | $-73M | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -229.3% | -68.6% | -47.4% | -34.0% | -43.3% | · | |
| ROE | 83.4% | -137.8% | -72.4% | -45.0% | -30.7% | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 18.2 | 5.2 | 9.0 | 18.1 | 21.1 | · | |
| Quick Ratio | 18.1 | 4.9 | 8.8 | 17.6 | 20.4 | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $-4.24 | $0.77 | $2.22 | $3.80 | $5.82 | · | |
| Cash Flow / Share | $-14.46 | $-1.45 | $-1.49 | $-2.15 | · | · | |
| Cash / Share | $10.24 | $0.66 | $0.46 | $0.87 | $3.22 | · | |
| EPS (TTM) | $-70.50 | $-34.03 | $-1.75 | $-2.33 | $-2.10 | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-696M | $-117M | $-118M | $-92M | $-69M | $-43M | |
| Market Cap | $506M | $2.77B | $3.06B | $8.78B | $8.64B | · | |
| P/E | -0.2 | -0.7 | -25.7 | -57.1 | -110.7 | · | |
| P/B | -3.1 | 28.7 | 20.3 | 35.0 | 39.9 | · | |
| P / Tangible Book | · | 28.7 | 20.3 | 35.0 | 39.9 | · | |
| P / Cash Flow | -3.5 | -27.8 | -30.5 | -103.1 | -124.9 | · | |
| P / FCF | -3.5 | -27.7 | -30.1 | -93.8 | -118.3 | · | |
| Dividend Yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | · | |
| Earnings Yield | -539.0% | -153.3% | -3.9% | -1.8% | -0.90% | · | |
| Payout Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | · | |
| Annual Payout | $0 | $0 | $0 | $0 | $0 | $0 |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $26M | $18M | $19M | $14M | $261M | $27M | $25M | $22M | $22M | $24M | $21M | $28M | $24M | $22M | $17M | $17M | |
| SG&A Expense | $22M | $18M | $17M | $14M | $13M | $7M | $6M | $7M | $7M | $8M | $7M | $8M | $8M | $9M | $8M | $7M | |
| Operating Expenses | $48M | $35M | $36M | $28M | $274M | $33M | $31M | $29M | $29M | $32M | $28M | $35M | $32M | $30M | $25M | $24M | |
| Operating Income | $-48M | $-35M | $-36M | $-28M | $-274M | $-33M | $-31M | $-29M | $-29M | $-32M | $-28M | $-35M | $-32M | $-30M | $-25M | $-24M | |
| Interest Income | $4M | $4M | $3M | $2M | $537.0K | $805.0K | $599.0K | $954.0K | $1M | $2M | $2M | $2M | $2M | $2M | $815.0K | $313.0K | |
| Other Non-op | $-15M | $-184M | $1.76B | $-785M | $-1.30B | $805.0K | $599.0K | $954.0K | $1M | $2M | $2M | $2M | $2M | $2M | $815.0K | $313.0K | |
| Net Income | $-63M | $-220M | $1.72B | $-813M | $-1.57B | $-32M | $-31M | $-28M | $-28M | $-31M | $-26M | $-33M | $-30M | $-28M | $-24M | $-24M | |
| EPS (Basic) | $-1.16 | $-5.11 | $63.95 | $-121.63 | $-251.24 | $-5.21 | $-25.12 | $-8.05 | $-0.41 | $-0.45 | $-0.38 | $-0.49 | $-0.45 | $-0.43 | $-0.51 | $-0.63 | |
| EPS (Diluted) | $-1.16 | $-5.11 | $63.95 | $-121.63 | $-251.24 | $-5.21 | $-25.12 | $-8.05 | $-0.41 | $-0.45 | $-0.38 | $-0.49 | $-0.45 | $-0.43 | $-0.51 | $-0.63 | |
| Shares (Basic) | 54,304,456 | 43,011,544 | · | 6,681,794 | 6,263,572 | 6,241,207 | · | 3,423,499 | 68,299,170 | 68,030,966 | · | 67,607,713 | 67,033,150 | 66,265,703 | · | 38,009,022 | |
| Shares (Diluted) | 54,304,456 | 43,011,544 | · | 6,681,794 | 6,263,572 | 6,241,207 | · | 3,423,499 | 68,299,170 | 68,030,966 | · | 67,607,713 | 67,033,150 | 66,265,703 | · | 38,009,022 | |
| EBITDA | $-48M | $-35M | · | $-28M | $-274M | $-33M | · | $-29M | $-29M | · | · | $-35M | $-32M | $-30M | · | $-24M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $108M | $170M | $396M | $160M | $191M | $50M | $82M | $53M | $76M | $45M | $31M | $45M | $32M | $42M | $58M | $61M | |
| Short-term Investments | $358M | $322M | $59M | $10M | $10M | $10M | $10M | $10M | $10M | $63M | $106M | $115M | $155M | $168M | $173M | $75M | |
| Prepaid Expense | $6M | $6M | $1M | $747.0K | $2M | $5M | $4M | $4M | $4M | $4M | $3M | $4M | $4M | $6M | $4M | $5M | |
| Other Current Assets | $3M | $3M | $2M | $1M | $449.0K | $297.0K | $380.0K | $285.0K | $272.0K | $507.0K | $475.0K | $667.0K | $539.0K | $459.0K | $2M | $2M | |
| Current Assets | $475M | $501M | $458M | $172M | $205M | $65M | $97M | $67M | $90M | $112M | $141M | $164M | $191M | $217M | $237M | $143M | |
| PP&E (Net) | $648.0K | $565.0K | $533.0K | $271.0K | $0 | $6M | $7M | $7M | $8M | $9M | $10M | $11M | $11M | $12M | $13M | $13M | |
| PP&E (Gross) | $738.0K | $618.0K | $558.0K | $272.0K | $0 | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $17M | $17M | $17M | |
| Accum. Depreciation | $90.0K | $53.0K | $25.0K | $1.0K | $0 | $12M | $11M | $11M | $10M | $9M | $8M | $7M | $6M | $5M | $5M | $4M | |
| Other Non-current Assets | $2M | $2M | $2M | $269.0K | $420.0K | $2M | $2M | $3M | $3M | $5M | $5M | $4M | $3M | $3M | $3M | $3M | |
| Total Assets | $481M | $507M | $464M | $176M | $205M | $109M | $143M | $116M | $142M | $167M | $198M | $223M | $251M | $278M | $299M | $206M | |
| Accounts Payable | $4M | $1M | $5M | $885.0K | $669.0K | $4M | $2M | $1M | $2M | $2M | $815.0K | $1M | $2M | $3M | $2M | $824.0K | |
| Accrued Liabilities | $20M | $15M | $20M | $18M | $58M | $9M | $13M | $9M | $8M | $7M | $11M | $10M | $7M | $5M | $8M | $6M | |
| Current Liabilities | $25M | $16M | $25M | $19M | $59M | $17M | $19M | $14M | $14M | $13M | $16M | $15M | $13M | $13M | $13M | $11M | |
| Capital Leases | $3M | $3M | $3M | $3M | $0 | $27M | $28M | $29M | $30M | $31M | $32M | $33M | $34M | $35M | $36M | $37M | |
| Total Liabilities | $681M | $657M | $628M | $2.40B | $1.71B | $43M | $46M | $43M | $44M | $44M | $47M | $48M | $47M | $47M | $49M | $48M | |
| Common Stock | $19.0K | $19.0K | $18.0K | $15.0K | $13.0K | $13.0K | $13.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $4.0K | |
| Retained Earnings | $-1.44B | $-1.37B | $-1.15B | $-2.88B | $-2.06B | $-489M | $-457M | $-426M | $-399M | $-371M | $-340M | $-314M | $-281M | $-251M | $-222M | $-198M | |
| AOCI | $-922.0K | $-706.0K | $41.0K | $12.0K | $14.0K | $23.0K | $22.0K | $68.0K | $-70.0K | $-87.0K | $-77.0K | $-280.0K | $-436.0K | $-174.0K | $-770.0K | $-1M | |
| Stockholders' Equity | $-200M | $-150M | $-164M | $-2.23B | $-1.51B | $66M | $97M | $73M | $98M | $123M | $151M | $175M | $204M | $230M | $251M | $159M | |
| Liabilities + Equity | $481M | $507M | $464M | $176M | $205M | $109M | $143M | $116M | $142M | $167M | $198M | $223M | $251M | $278M | $299M | $206M | |
| Shares Outstanding | 54,455,751 | 54,185,582 | 38,720,196 | 9,026,922 | 125,645,952 | 124,851,547 | 6,238,799 | 68,663,065 | 68,357,884 | 68,215,771 | 67,891,311 | 67,785,469 | 67,433,560 | 66,934,897 | 65,996,138 | 38,393,211 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $9M | $9M | $7M | $8M | $2M | $2M | $2M | $2M | $3M | $3M | $2M | $3M | $4M | $4M | $4M | $3M | |
| Restructuring | · | · | $0 | $-1M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-25M | $-38M | $-23M | $-54M | $-35M | $-31M | $-24M | $-23M | $-22M | $-30M | $-24M | $-28M | $-24M | $-24M | $-18M | $-19M | |
| CapEx | $120.0K | $48.0K | $314.0K | $244.0K | $152.0K | $231.0K | $72.0K | $34.0K | $9.0K | $114.0K | $111.0K | $465.0K | $399.0K | $94.0K | $321.0K | $298.0K | |
| Investing Cash Flow | $-37M | $-263M | $-49M | $-244.0K | $646.0K | $-230.0K | $-72.0K | $-34.0K | $53M | $44M | $10M | $41M | $14M | $6M | $-97M | $13M | |
| Stock Issued | · | · | $50M | $20M | $0 | $0 | $-22.0K | $111.0K | $-92.0K | $278.0K | $-15.0K | $392.0K | $579.0K | $4M | $106.0K | $4M | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | · | · | · | · | $4M | · | · | |
| Financing Cash Flow | $-106.0K | $75M | $308M | $22M | $175M | $-606.0K | $53M | $41.0K | $-31.0K | $96.0K | $25.0K | $176.0K | $218.0K | $3M | $112M | $4M | |
| Net Change in Cash | $-62M | $-227M | $236M | $-32M | $141M | $-32M | $29M | $-23M | $31M | $14M | $-14M | $13M | $-10M | $-15M | $-3M | $-2M | |
| Free Cash Flow | · | $-38M | · | · | · | $-31M | · | · | · | · | · | · | · | $-24M | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -18.3% | -71.3% | · | -556.2% | -907.1% | -23.5% | · | -16.3% | -14.2% | · | · | -15.5% | -12.6% | -11.1% | · | -10.2% | |
| ROE | 7.4% | 520.6% | · | 75.5% | 223.6% | -34.4% | · | -22.2% | -18.4% | · | · | -19.9% | -15.8% | -13.4% | · | -12.2% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 19.1 | 31.1 | · | 9.2 | 3.5 | 3.9 | · | 4.7 | 6.5 | · | · | 10.7 | 15.1 | 17.2 | · | 12.9 | |
| Quick Ratio | 18.8 | 30.6 | · | 9.0 | 3.4 | 3.6 | · | 4.4 | 6.2 | · | · | 10.4 | 14.7 | 16.7 | · | 12.3 |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-3.68 | $-2.78 | · | $-246.54 | $-11.98 | $0.53 | · | $1.06 | $1.43 | · | · | $2.58 | $3.03 | $3.44 | · | $4.13 | |
| Cash Flow / Share | · | $-0.89 | · | · | · | $-0.25 | · | · | · | · | · | · | · | $-0.37 | · | · | |
| Cash / Share | $1.98 | $3.13 | · | $17.78 | $1.52 | $0.40 | · | $0.77 | $1.11 | · | · | $0.66 | $0.48 | $0.63 | · | $1.58 | |
| EPS (TTM) | $-63.95 | $-314.03 | · | $-403.20 | $-289.62 | $-38.79 | · | $-9.29 | $-1.73 | $-1.82 | · | $-1.88 | $-2.02 | $-2.15 | · | $-2.30 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $628M | $-883M | · | $-2.45B | $-1.66B | $-119M | · | $-112M | $-118M | $-122M | · | $-116M | $-106M | $-98M | · | $-86M | |
| Market Cap | $1.00B | $967M | · | $440M | $4.07B | $1.79B | · | $961M | $1.37B | · | · | $2.87B | $4.17B | $7.20B | · | $3.06B | |
| P/E | -0.3 | -0.1 | · | -0.1 | -0.1 | -0.4 | · | -1.5 | -11.6 | -26.0 | · | -22.6 | -30.6 | -50.0 | · | -34.6 | |
| P/B | -5.0 | -6.4 | · | -0.2 | -2.7 | 27.1 | · | 13.2 | 13.9 | · | · | 16.4 | 20.4 | 31.3 | · | 19.3 | |
| P / Tangible Book | · | · | · | · | · | 27.1 | · | 13.2 | 13.9 | 26.3 | · | 16.4 | 20.4 | 31.3 | · | 19.3 | |
| P / Cash Flow | · | -25.3 | · | · | · | -57.7 | · | · | · | · | · | · | · | -296.8 | · | · | |
| Earnings Yield | -347.4% | -1760.3% | · | -827.6% | -893.9% | -270.1% | · | -66.4% | -8.6% | -3.8% | · | -4.4% | -3.3% | -2.0% | · | -2.9% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Beneficio neto | $-696M | $-117M | $-118M | $-92M | $-69M |
| EPS Diluido | $-70.50 | $-34.03 | $-1.75 | $-2.33 | $-2.10 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | 18.2 | 5.2 | 9.0 | 18.1 | 21.1 |
| Ratio Rápido | 18.1 | 4.9 | 8.8 | 17.6 | 20.4 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-144M | $-100M | $-101M | $-94M | $-73M |
Propietarios institucionales (13F) 111 declarantes · $903.3M total · A fecha de 30 de septiembre de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
111
Valor en tenencia
$903.3M
Nuevas posiciones
39
Posiciones cerradas
17
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 39 (+5 vs trimestre anterior) | 17 (+7 vs trimestre anterior) | 34 (+8 vs trimestre anterior) | 20 (+10 vs trimestre anterior) | +8.0M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| TCG Crossover Management, LLC | $104 441 366 | 5 673 078 | 11,56% | Acciones |
| FMR LLC | $90 800 863 | 4 932 149 | 10,05% | Acciones |
| FCPM III SERVICES B.V. | $75 800 487 | 4 117 354 | 8,39% | Acciones |
| BlackRock, Inc. | $63 847 850 | 3 468 107 | 7,07% | Acciones |
| Venrock Adviser, LLC | $55 998 047 | 3 041 719 | 6,20% | Acciones |
| STATE STREET CORP | $48 166 746 | 2 616 336 | 5,33% | Acciones |
| Frazier Life Sciences Management, L.P. | $46 833 917 | 2 543 939 | 5,18% | Acciones |
| RA CAPITAL MANAGEMENT, L.P. | $44 222 569 | 2 402 095 | 4,90% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $38 372 478 | 2 084 328 | 4,25% | Acciones |
| Caligan Partners LP | $35 440 465 | 1 925 066 | 3,92% | Acciones |
| Paradigm Biocapital Advisors LP | $32 217 500 | 1 750 000 | 3,57% | Acciones |
| GREAT POINT PARTNERS LLC | $31 297 000 | 1 700 000 | 3,46% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $19 563 726 | 1 062 469 | 2,17% | Acciones |
| NEXTBio Capital Management LP | $16 369 509 | 889 164 | 1,81% | Acciones |
| Nantahala Capital Management, LLC | $15 556 450 | 845 000 | 1,72% | Acciones |
| ADAR1 Capital Management, LLC | $12 530 325 | 680 626 | 1,39% | Acciones |
| Logos Global Management LP | $11 966 500 | 650 000 | 1,32% | Acciones |
| Rosalind Advisors, Inc. | $11 940 726 | 648 600 | 1,32% | Acciones |
| NAN FUNG TRINITY (HK) LTD | $11 902 986 | 646 550 | 1,32% | Acciones |
| BRAIDWELL LP | $10 550 845 | 573 104 | 1,17% | Acciones |
| BOOTHBAY FUND MANAGEMENT, LLC | $10 285 704 | 558 702 | 1,14% | Acciones |
| VANGUARD GROUP INC | $10 074 870 | 770 250 | 1,12% | Acciones |
| UBS Group AG | $9 081 248 | 493 278 | 1,01% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $7 880 713 | 428 067 | 0,87% | Acciones |
| SPHERA FUNDS MANAGEMENT LTD. | $7 666 237 | 416 417 | 0,85% | Acciones |
| Woodline Partners LP | $6 990 700 | 379 723 | 0,77% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $6 266 101 | 340 364 | 0,69% | Acciones |
| GOLDMAN SACHS GROUP INC | $6 054 902 | 328 892 | 0,67% | Acciones |
| NORTHERN TRUST CORP | $6 052 141 | 328 742 | 0,67% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $5 535 961 | 300 704 | 0,61% | Acciones |
| Clearline Capital LP | $5 251 931 | 285 276 | 0,58% | Acciones |
| BANK OF AMERICA CORP /DE/ | $3 272 175 | 177 739 | 0,36% | Acciones |
| CITADEL ADVISORS LLC | $2 953 222 | 160 414 | 0,33% | Acciones |
| Eversept Partners, LP | $2 755 627 | 149 681 | 0,31% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $2 234 937 | 121 398 | 0,25% | Acciones |
| Bank of New York Mellon Corp | $1 799 062 | 97 722 | 0,20% | Acciones |
| MARSHALL WACE, LLP | $1 760 788 | 95 643 | 0,19% | Acciones |
| Nuveen, LLC | $1 745 544 | 94 815 | 0,19% | Acciones |
| AXIOM INVESTORS LLC /DE | $1 695 653 | 92 105 | 0,19% | Acciones |
| XTX Topco Ltd | $1 521 494 | 82 645 | 0,17% | Acciones |
| Jump Financial, LLC | $1 305 066 | 70 889 | 0,14% | Acciones |
| Invesco Ltd. | $1 257 421 | 68 301 | 0,14% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1 189 286 | 64 600 | 0,13% | Opción de venta |
| CITIGROUP INC | $1 162 224 | 63 130 | 0,13% | Acciones |
| MORGAN STANLEY | $1 133 338 | 61 561 | 0,13% | Acciones |
| RHUMBLINE ADVISERS | $1 059 081 | 57 528 | 0,12% | Acciones |
| ALPS ADVISORS INC | $1 012 513 | 54 998 | 0,11% | Acciones |
| D. E. Shaw & Co., Inc. | $1 006 493 | 54 671 | 0,11% | Acciones |
| JOHNSON & JOHNSON | $989 206 | 53 732 | 0,11% | Acciones |
| Rafferty Asset Management, LLC | $898 739 | 48 818 | 0,10% | Acciones |
Activistas y propietarios del %+ 5 4 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×19 presentaciones | 21 de julio de 2026 | 19,90% | Enmienda | Campaña de la junta directiva | SEC |
| ForGrowth III PA B.V., Forbion Growth Opportunities Fund III Cooperatief U.A., Forbion Growth III Management B.V. | 23 de diciembre de 2025 | 9,99% | Presentación inicial | Campaña de la junta directiva | SEC |
| Reprogrammed Interchange LLC, Reid Hoffman ×9 presentaciones | 17 de octubre de 2025 | 17,60% | Enmienda | · | SEC |
| 5AM Ventures VI, L.P., 5AM Partners VI, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, Andrew J. Schwab, Kush Parmar ×3 presentaciones | 9 de julio de 2025 | 3,50% | Enmienda | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 25 insiders · 10 directivos · 16 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Jean-Paul Kress | CEO and Chairman | 5 de diciembre de 2025 A | · | 0 | 0 | $0 |
| Robert Ang | PRESIDENT AND CEO | 6 de mayo de 2025 F | 911 318 | 0 | 0 | $0 |
| Sandesh Mahatme | CFO | 5 de diciembre de 2025 A | 0 | 0 | 0 | $0 |
| Han Wook Choi | Chief Financial Officer | 1 de mayo de 2025 F | 51 280 | 0 | 0 | $0 |
| Nathan D. Jorgensen | CHIEF FINANCIAL OFFICER | 6 de mayo de 2024 F | 189 403 | 0 | 0 | $0 |
| Qing Che Zuraw | Chief Development Officer | 5 de diciembre de 2025 A | 937 080 | 0 | 0 | $0 |
| Tirtha Chakraborty | Chief Sci Off & Head Tech Ops | 6 de mayo de 2025 F | 217 416 | 0 | 0 | $0 |
| Eyal C. Attar | CHIEF MEDICAL OFFICER | 13 de febrero de 2025 S | 126 625 | 0 | 0 | $0 |
| Amy Quinlan | Vice President of Finance | 6 de noviembre de 2024 F | 50 312 | 0 | 0 | $0 |
| Christopher Slapak | Chief Medical Officer | 1 de febrero de 2022 A | · | 0 | 0 | $0 |
| David Zaccardelli | Consejero | 7 de julio de 2026 A | · | 0 | 0 | $0 |
| Wouter Joustra | Consejero | 11 de junio de 2026 A | · | 0 | 0 | $0 |
| Andrew David Levin | Consejero | 11 de junio de 2026 A | · | 0 | 0 | $0 |
| Michel Detheux | Consejero | 11 de junio de 2026 A | · | 0 | 0 | $0 |
| Fouad Namouni | Consejero | 11 de junio de 2026 A | · | 0 | 0 | $0 |
| Alexander Cumbo | Consejero | 11 de junio de 2026 A | · | 0 | 0 | $0 |
| Daniella Beckman | Consejero | 11 de junio de 2026 A | · | 0 | 0 | $0 |
| Erez Kalir | Consejero | 11 de junio de 2026 A | · | 0 | 0 | $0 |
| Sarah Burgess Reed | Consejero | 8 de septiembre de 2025 A | · | 0 | 0 | $0 |
| Joshua Resnick | Consejero | 22 de mayo de 2025 A | · | 0 | 0 | $0 |
| Sven Ante Lundberg | Consejero | 22 de mayo de 2025 A | · | 0 | 0 | $0 |
| David Charles Lubner | Consejero | 22 de mayo de 2025 A | · | 0 | 0 | $0 |
| Matthew R Patterson | Consejero | 22 de mayo de 2025 A | · | 0 | 0 | $0 |
| Kush Parmar | Consejero | 14 de junio de 2022 A | 1 766 634 | 0 | 0 | $0 |
| Alexandria Venture Investments, LLC | Propietario del 10% | 9 de febrero de 2021 C | 282 804 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 22 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,99% | 21 644 NS | 31 de julio de 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,26% | 59 675 NS | 31 de julio de 2026 | N-PORT |
| IWC · iShares Trust | 0,22% | 138 968 SH | 11 de septiembre de 2026 | Diario |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,20% | 28 544 SH | 23 de octubre de 2026 | Diario |
| FFSM · FIDELITY COVINGTON TRUST | 0,16% | 115 450 NS | 31 de julio de 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,07% | 4 461 SH | 23 de octubre de 2026 | Diario |
| PWS · Pacer Funds Trust | 0,07% | 815 NS | 31 de julio de 2026 | N-PORT |
| IWO · iShares Trust | 0,04% | 263 868 SH | 11 de septiembre de 2026 | Diario |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,03% | 29 989 SH | 19 de agosto de 2026 | Diario |
| IWM · iShares Trust | 0,03% | 1 046 684 SH | 11 de septiembre de 2026 | Diario |
| RSSL · Global X Funds | 0,03% | 19 535 NS | 31 de julio de 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 234 796 SH | 19 de agosto de 2026 | Diario |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 20 712 SH | 22 de octubre de 2026 | Diario |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 492 007 SH | 19 de agosto de 2026 | Diario |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 11 048 SH | 19 de agosto de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | 0,01% | 61 141 SH | 19 de agosto de 2026 | Diario |
| WSML · iShares Trust | 0,01% | 2 468 SH | 11 de septiembre de 2026 | Diario |
| ITOT · iShares Trust | 0,00% | 67 560 SH | 11 de septiembre de 2026 | Diario |
| IWV · iShares Trust | 0,00% | 13 099 SH | 11 de septiembre de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1 550 885 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3 390 SH | 19 de agosto de 2026 | Diario |
| IWN · iShares Trust | · | 117 140 SH | 11 de septiembre de 2026 | Diario |
VOR Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 13 analistas
COMPRA
Objetivo mediano
$40.00
+119,1%
5 38,5%
Compra fuerte
6 46,2%
Compra
2 15,4%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
8 analistas · 2026-10-19Objetivo medio $39.00 +113,6%
← Por Debajo de Todos los Objetivos
Precio Actual $18.26
Mín$27.00
Media$39.00
Máx$50.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| VOR | $506M | -0.2 | · | · | 83.4% | · |
| ORIC | $806M | -5.6 | · | · | -36.5% | · |
| DMRA | · | · | 38.3% | -17981.1% | -167.0% | · |
| TSHA | $1.57B | -16.2 | 17.3% | -1115.3% | -44.0% | · |
| SNDX | $1.84B | -6.4 | 627.8% | -165.6% | -257.1% | · |
| BCAX | $953M | -6.7 | · | · | -33.0% | · |
| VSTM | $600M | -2.6 | 209.1% | -677.6% | -449.2% | · |
| REPL | $633M | -2.3 | · | · | -146.2% | · |
| AVBP | $854M | -4.7 | · | · | -59.7% | · |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 11, 2026